Abirakast (Abiraterone acetate) is a recently discovered hormonal therapy for adult male patients suffering from prostate cancer. Abirakast 250 mg (Abiraterone acetate) is an oral drug which inhibits the action of proteins (CYP17A1 enzyme) that are responsible for producing a male hormone called testosterone.